Zdrowie i gospodarka · 02/01/2026
FDA Withdraws MYSOLINE Suspension from Sale Due to Safety or Effectiveness Concerns
The FDA has determined that MYSOLINE suspension, 250 mg/5 mL, was withdrawn from sale due to safety or effectiveness concerns, and will not accept new applications for this product.